Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study

Abstract

BackgroundThe metabolic syndrome (MetS) is a cluster of risk factors associated with morbidity from cardiovascular disease (CVD) and associated mortality. Russia has one of the highest CVD mortality rates in the world. However, the prevalence of MetS in Russia remains largely unknown. The aim of this study is to estimate the prevalence of MetS and its components in an urban Russian setting.MethodsAltogether, 3705 Russian adults aged 18-90 years were enrolled in a cross-sectional study in Arkhangelsk (Northwest Russia). All subjects completed a questionnaire and underwent a physical examination. Blood samples were taken and analyzed in TromsØ, Norway. Three separate modified definitions of MetS were used, namely, the National Education Cholesterol Education Program Adult Treatment Panel III (NCEP), the American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI) and the International Diabetes Federation (IDF). To ensure comparability of the findings, the prevalence data were standardized using world and European standard populations and Russian population.ResultsThe age-standardized (Segi's world standard population) prevalence rates of the MetS among women were 19.8% (95% CI: 18.1-21.5), 20.6% (95% CI: 18.9-22.3) and 23.1% (95% CI: 21.3-24.9) by the NCEP, AHA/NHLBI and IDF criteria, respectively. The corresponding rates for men were 11.5% (95% CI: 10.1-12.9), 13.7% (95% CI: 12.2-15.2) and 11.0% (95% CI: 9.7-12.4). Among subjects with MetS, central obesity was more common among women, while elevated triglycerides and blood glucose were more common among men. Almost perfect agreement was found between the NCEP and AHA/NHLBI criteria (κ = 0.94). There was less agreement between the used definitions of MetS in men than in women.ConclusionsWhile the prevalence of MetS among Russian women is comparable to the data for Europe and the U.S., the prevalence among Russian men is considerably lower than among their European and North-American counterparts. Our results suggest that MetS is unlikely to be a major contributor to the high cardiovascular mortality among Russian men. Further studies of MetS determinants and associated cardiovascular risk are needed for a better understanding of the mechanisms leading to the exceptionally high cardiovascular mortality in Russia.

The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)

“…В другом отчете была представлена достаточно консервативная оценка распространенности СД (3,2%, 3,5/110 млн взрослого населения РФ) [3]. Следует от-метить, что выборки, на основании которых получены более ранние данные, вызывают сомнения в отношении репрезентативности по отношению ко всему взрослому населению РФ [4]. Кроме того, результаты более поздних эпидемиологических исследований, проведенных в не-которых регионах РФ, показали, что распространенность СД может быть выше, чем сообщалось ранее [5].…”

Síndrome metabólica em idosos assistidos na atenção terciária à saúde em Curitiba, Paraná: prevalência e associação com saúde, capacidade funcional, estilo de vida e fatores sociodemográficos

“…O aumento da prevalência da SM com o avançar da idade é fato frequentemente citado na literatura, mas é importante observar que em vários desses estudos [36][37][38][39][40][41] as faixas etárias analisadas incluíram os idosos como um grupo homogêneo, com idades a partir de 60 ou 65 anos, e geralmente comparados a faixas etárias inferiores. Ao analisar os subgrupos etários como no presente estudo (idosos mais jovens com…”

Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies

“…В ходе исследования NATION было обнаружено, что 35% опрошенных взрослых имели избыточную массу тела (ИМТ≥25-<30 кг/м 2 ), 31% -ожирение (ИМТ≥30 кг/м 2 ), что было сопряжено с рас-пространенностью предиабета в 18,6% и 33,1% случаев соответственно [1]. Данные проведенного в Архангельске одномоментного исследования показывают, что стан-дартизированная по возрасту частота метаболического синдрома (по критериям Международной Федерации Диабета) составляет 23,1% среди женщин и 11,0% -среди мужчин, что подтверждает очевидное повышение риска СД2 в России [4].…”